Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZD1839 in Advanced Renal Cell Carcinoma
NCT00014183Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2001
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in renal cell carcinoma (RCC), sponsored by University of Maryland, Baltimore. Started Jan 2001; status: completed.
02
Drugs
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00014183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014183.